Life Sciences Commercialisation in Finland: Overview
A Q&A guide to life sciences commercialisation in Finland. This Q&A provides a high-level overview of key practical
We hope you find what you are looking for. Please let us know if we can assist you.
A Q&A guide to life sciences commercialisation in Finland. This Q&A provides a high-level overview of key practical
A Q&A guide to life sciences regulation in Finland. This Q&A provides a high-level overview of key practical
Continued High Activity Level in H1/2023 for D&I Transaction Powerhouse
In this issue of the D&I Quarterly, we are rethinking holding structures and taking a look at Finnish
I have seen some excellent negotiators over the years, but I must admit I’ve seen some really lousy
Sustainability and ESG have become a top priority for businesses, as the general awareness on these topics is
The Inherent Tension Between Holding Companies and Tax Abuse Distinguishing between genuine and artificial arrangements is often a
Social infrastructure assets, such as hospitals, fire stations and day care centres, continue to draw a considerable amount
Gathering views from various stakeholders is an essential element of legislative processes. Influencing activities directed at law-making take
In order to meet the requirements of the rapidly changing business environment and increasing cross-border regulation relating to